Speakers

Grégory Vernier is the Head of Business Development and a member of the Management Committee at Fabentech, a French biopharmaceutical company dedicated to biodefense and pandemic preparedness. Since joining Fabentech in 2021, he has led the company’s international growth strategy, forging global partnerships and guiding the market access and public-affairs agenda for antibody-based therapeutics addressing biothreats and emerging infectious diseases.

With more than 18 years of experience in the life-sciences industry, Dr Vernier combines scientific expertise with a strong business and policy background. Before joining Fabentech, he directed a healthcare industry cluster for over 8 years, where he supported over 100 biotech, medtech, and digital-health companies and advanced collaborative R&D and industrial initiatives.

Trained as a biochemist, Dr Vernier conducted post-doctoral research at Harvard Medical School and the Université Libre de Bruxelles, publishing several peer-reviewed articles on toxin structures and membrane-protein interactions. He also holds master’s degrees in biotechnology management from Grenoble École de Management and in corporate finance from HEC Paris.

Through his career, Dr Vernier has worked to bridge science, industry, and policy to strengthen Europe’s sovereignty and resilience in medical countermeasures.